Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-290-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20121023.17.2-290-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, ladies and gentlemen, Commissioner, for years this Parliament has been unable to overcome the ideological divide between pro-Palestine and pro-Israel positions, even when the debate is on purely technical issues.
The agreement on Conformity Assessment and Acceptance of Industrial Products provides for the extension of some of the benefits of the internal market to sectors that are already aligned but that require further standardisation in order to facilitate access to the market for industrial products and remove technical barriers. The agreement is of a commercial nature, because it allows easier European access to markets for pharmaceutical products and completion of the current policy of exchange between the EU and the Mediterranean countries.
Any debate on doubts regarding the origins of certain products exported should be commercially based, and we would not have such doubts had the Council approved the Regulation on indications of origin, which has instead been held up and in fact risks being shelved due to lack of political understanding and opposing interests. I call on the House to attempt to distinguish between the commercial and political assessments, to avoid sterile manipulation of these issues and to vote in favour of the proposal."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples